Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Robert Redman has had many treatments for brain and spinal cord cancer in the past 17 years, including proton, gamma and ...

Fred Hutch Cancer Center is inviting applications for innovative projects to address and improve multiple social determinants of health among under represented communities in Washington State, ...

Save the Date: the Sloan Precision Oncology Institute is hosting a Theranostics Symposium on February 28, 2025. This symposium will feature a panel of local and national leaders in the field who will ...

“As a Seattle native, I have always been aware of the amazing research and innovation at Fred Hutch. When my life was touched by cancer, I knew it was time to get more involved and support this ...

The Prevention Center shared resource (PCSR) was founded with the goal of facilitating transdisciplinary, collaborative research focused on the prevention and mitigation of disease. Since 2004, over ...

Dr. Eddie Méndez was a physician-scientist and cherished colleague at Fred Hutch who died of cancer in 2018 at age 45. An expert in head and neck cancers, Méndez was known for being passionate about ...

As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...

Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...

Vaccines are arguably one of the most important medical innovations in human history. When it comes to which diseases have successfully been targeted with vaccines, however, the playing field is far ...

Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as ...